Regulators ‘more efficient at approving drugs’
January 19, 2015Research and Development, Sales and Marketing EMA, EMA), FDA, Health Canada, PMDA)., Pharmaceutical and Medical Devices Agency, Swissmedic, TGA, approvals, cirs, reuters
Global regulatory bodies have become faster at approving new drug products more quickly and consistently, according to a new analysis …
Genentech and Human Longevity ink genomics deal
January 19, 2015Research and Development, Sales and Marketing 23andME, DNA, Genentech, Illumina, hli, human longevity
Genentech is partnering with US genetics firm Human Longevity (HLI) in another 2015 genomics deal to continue its push into …
Boehringer gains EU approval for Ofev
January 19, 2015Sales and Marketing Boehringer, Esbriet, IPF, InterMune, ingelheim, nintedanib, ofev
The European Commission has approved Boehringer Ingelheim’s Ofev as a treatment for idiopathic pulmonary fibrosis (IPF). The approval follows the …
Roche buys French biotech for €470 million
January 19, 2015Sales and Marketing Foundation, Genentech, Orphan, Roche, TRO19622, olesoxime, sma, trophos
Roche is buying France-based biotech Trophos in a deal worth up to €470 million in order to gain access to …
Astellas takes senior head from AstraZeneca
January 19, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Astellas, AstraZeneca, eric Terhaerdt
Eric Terhaerdt has been named as the senior vice president of global development operations at Astellas Pharma. Terhaerdt, who joins the …
Interview: Rajeev Venkayya, president of Takeda Vaccine
January 19, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bush, Ebola, Gates, Rajeev Venkayya, Takeda, brett wells, vaccines
Rajeev Venkayya is the president of the global vaccine business unit at Takeda Pharmaceuticals. He has served as special assistant …
AbbVie Hep C combo pill ready for Europe
January 16, 2015Medical Communications AbbVie, Exviera, FDA, HIV, Viekira Pak, Viekirax, harvoni, hep C, sovaldi
The European Commission has approved AbbVie’s Viekirax and Exviera for the treatment of chronic hepatitis C (HCV). Viekirax (ombitasvir/paritaprevir/ritonavir) and …
GSK double complaint ruled out by PMCPA
January 16, 2015Medical Communications, Sales and Marketing ABPI, COPD, GSK, PMCPA, Relvar, Seretide
Complaints questioning the promotion of two of GlaxoSmithKline’s chronic obstructive pulmonary disease (COPD) drugs have been ruled out by a …
FDA approves novel obesity device
January 16, 2015Medical Communications, Sales and Marketing EnteroMedics, FDA, Novo, VBLOC, diabetes, obesity, type 2
The US Food and Drug Administration has shown the green light to US firm EnteroMedics’ new obesity device VBLOC that …
MedDay appoints senior head from Sanofi
January 16, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Philippe Goupit, Sanofi, medday
Paris-based biotech MedDay has appointed Philippe Goupit as an independent non-executive director. Goupit was until recently the vice president of …
CDF chair: more treatment reviews to come
January 16, 2015Sales and Marketing CDF, Cancer Drugs Fund, NHS, NHS England, NICE, peter clark
The chair of NHS England’s cancer drugs fund has said there is likely to be more reviews of affordable treatments …
Janssen privy to new pricing scheme and see NICE nod
January 16, 2015Sales and Marketing Janssen, NHS, NICE, hep C, hepatitis, olysio, ribavirin, simeprevir
Janssen’s hepatitis C drug Olysio has been approved by NICE whilst also reaching a novel ‘pay if you clear’ pricing …
NICE approves Sovaldi
January 16, 2015Sales and Marketing Gilead, NHS, NICE, hep C, hepatitis, pharma, sofosbuvir, sovaldi
NICE has recommended Sovaldi in final draft guidance and extended its scope, despite concerns over the price of the blockbuster …
Boehringer complaint ruled out by PMCPA
January 15, 2015Medical Communications, Sales and Marketing ABPI, Boehringer, COPD, PMCPA, Striverdi, olodaterol
A complaint made by a pharmacist stating that the artwork image for Boehringer Ingelheim’s COPD drug Striverdi is misleading has …
Sanofi and Boehringer partner on biologics manufacturing
January 15, 2015Manufacturing and Production, Sales and Marketing Boehringer, Sanofi, antibodies, biologics, cardiovascular, diabetes, mabs, manufacturing, monoclonal, oncology
Boehringer Ingelheim will help Sanofi extend its manufacturing capabilities for biologics in a new alliance, the companies have announced. Boehringer’s …
Sharing trial data should be ‘expected norm’ says US think-tank
January 15, 2015Medical Communications, Research and Development, Sales and Marketing FDA, Goldacre, Institute of Medicine, clinical trials, transparency
Clinical trial data is in the public interest and should be shared no less than 30 days following regulatory approval …
NICE releases reflux disease guidelines
January 15, 2015Sales and Marketing NHS, NICE, UK, gor, gord, h2ra
NICE has released new guidelines providing doctors with advice on how to treat gastro-oesophageal reflux disease (GORD) in young people. …
HSCIC appoints new specialist
January 15, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing HSCIC, andy kinnear
The Health and Social Care Information Centre (HSCIC) has appointed Andy Kinnear as a specialist. He will join the organisation …
AstraZeneca’s troubled Brilinta gets welcome lift
January 14, 2015Sales and Marketing AstraZeneca, Brilinta, FDA, US Department of Justice, acute coronary syndrome, ticagrelor
AstraZeneca has reported positive primary endpoint results for its anti-clogging drug Brilinta to treat patients who have had a heart …
Biogen Idec buys Convergence
January 14, 2015Sales and Marketing BG00010, Biogen IDEC, CNV1014802, Colombia University Medical Center, Convergence, Neublastin
Biogen Idec is to acquire independent UK-based Convergence Pharmaceuticals to strengthen its pipeline of drugs for pain management in a …
Latest content
NIHR chief scientific adviser visits Huddersfield health innovation campus
One in three UK women with migraine say symptoms taken less seriously
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer
